Discovery of Novel AAV Capsids for Osteoarthritis Gene Therapy

被引：0
|
作者：
Maeda, Yukiko [1 ]
Gao, Guangping [1 ]
Tai, Phillip W. L. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
344
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [31] AAV Gene Therapy: A Novel Treatment for Food Allergy
    Visiedo, Miguel Gonzalez
    Markusic, David M.
    MOLECULAR THERAPY, 2021, 29 (04) : 183 - 183
  • [32] A novel AAV-based gene therapy for glaucoma
    Wu, Ling
    Maturana, Carola
    Yao, Zuliang
    Wang, Wei
    Liang, Bo
    Hong, Laura
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [33] CAP-001: Systemic AAV Gene Therapy with Next Generation Capsids for MPS II Disease
    Ou, Li
    Octeau, Christopher
    Bonet, Bailey
    Lam, Kevin
    Siemian, Justin
    Dreher, Renee
    Roxas, Kristina
    Jeffreys, David
    Thomas, Shelby
    Grepo, Nicole
    Sandrock, Robert
    Cockrell, Adam
    Scherrer, Jon
    Ressler, Reed
    Wheeler, Brandon
    Badger, Drew
    Knoll, Allison
    Goeden, Nick
    MOLECULAR THERAPY, 2022, 30 (04) : 223 - 223
  • [34] Developability Assessment of Novel AAV Capsids and Payloads at Early Preclinical Stage to Enable Development of Gene Therapies
    Placidi, Matteo P.
    Ramachandrareddy, Himabindu
    Vass, Robert
    Alvarez, David
    Dhanasekaran, Kumar
    MOLECULAR THERAPY, 2024, 32 (04) : 35 - 35
  • [35] Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
    Wang, Lili
    Bell, Peter
    Somanathan, Suryanarayan
    Wang, Qiang
    He, Zhenning
    Yu, Hongwei
    McMenamin, Deirdre
    Goode, Tamara
    Calcedo, Roberto
    Wilson, James M.
    MOLECULAR THERAPY, 2015, 23 (12) : 1877 - 1887
  • [36] Novel AAV Capsids for Intravitreal Delivery: Identifying and Characterizing Novel AAV Variants in Non-Human Primates
    Guerin, Karen
    Geller, Scott
    Flannery, John G.
    Isacoff, Ehud
    Beltran, William A.
    Byrne, Leah C.
    Ozturk, Bilge E.
    Mozayeni, Cyrus
    MOLECULAR THERAPY, 2022, 30 (04) : 557 - 557
  • [37] Gene replacement therapy for telethonin related limb-girdle muscular dystrophy R7 utilizing novel myotrophic AAV capsids
    Gushchina, L.
    Bradley, A.
    Terry, K.
    Lay, J.
    Frair, E.
    Vetter, T.
    Rohan, N.
    Cox, G.
    Wolfe, S.
    Emerson, C.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S114 - S114
  • [38] Prevalence of Neutralizing Antibodies Against AAV2 and AAV9 Capsids in Propionic Acidemia (PA): Implications for Systemic Gene Therapy
    Hall, Camryn S.
    Sloan, Jennifer L.
    Galarreta, Carolina I.
    Shchelochkov, Oleg
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2024, 32 (04) : 298 - 298
  • [39] A novel gene therapy approach for canine osteoarthritis
    Campbell, S. E.
    Nasir, L.
    Argyle, D. J.
    Gault, E. A.
    Bennett, D.
    RHEUMATOLOGY, 2001, 40 : 102 - 103
  • [40] Exploring Upstream Process Conditions to Improve Productivity of Novel AAV Capsids
    Acharya, Hari
    Morales, Heidy
    Granados, Jesse
    Troisi, Elissa
    Volpe, Lysa-Anne
    MOLECULAR THERAPY, 2023, 31 (04) : 783 - 783
12345